Marie-Laure Pons has join our team in order to perform a CIFRE PhD in collaboration with the SHIMADZU company. Her project is on the devolpment of innovative approaches by mass spectrometry to detect and quantify biomarkers of interest in neurodegenerative diseases like Parkinson disease, lewy body dementia and Alzheimer disease.